Preventive cardiology for the aging population: how can we better design clinical trials of statins?
AS Wierzbicki - Expert Review of Cardiovascular Therapy, 2024 - Taylor & Francis
Introduction Older adults form a fast-increasing proportion of the world population. However,
gains in increasing quantity of life have not been accompanied by similar gains in quality of …
gains in increasing quantity of life have not been accompanied by similar gains in quality of …
Targeting hypercholesterolaemia: challenges and opportunities
F Crea - European Heart Journal, 2023 - academic.oup.com
Article entitled '2023 Update on European Atherosclerosis Society Consensus Statement on
Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance'by …
Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance'by …
[HTML][HTML] Effect of Adding Apolipoprotein B Testing on the Prevalence of Dyslipidemia and Risk of Cardiovascular Disease in the Korean Adult Population
R Choi, SG Lee, EH Lee - Metabolites, 2024 - mdpi.com
Traditional lipid parameters—including total cholesterol (TC), triglycerides (TG), low-density
lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and non-HDL …
lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and non-HDL …
The year in cardiovascular medicine 2023: the top 10 papers in dyslipidaemias
L Tokgozoglu, C Orringer… - European Heart …, 2024 - academic.oup.com
New insights and treatment options for dyslipidemia and atherosclerotic cardiovascular
disease. CV, cardiovascular; hs-CRP, high-sensitivity C-reactive protein; LDL-C, low-density …
disease. CV, cardiovascular; hs-CRP, high-sensitivity C-reactive protein; LDL-C, low-density …
[HTML][HTML] Exploring Utilization and Establishing Reference Intervals for the Apolipoprotein B Test in the Korean Population
R Choi, SG Lee, EH Lee - Diagnostics, 2023 - mdpi.com
We investigated the reference intervals for Apolipoprotein B (ApoB), a valuable biomarker
for cardiovascular diseases, in Korean adults who had undergone health check-ups and …
for cardiovascular diseases, in Korean adults who had undergone health check-ups and …
Achievement of Guideline-Recommended Targets for Secondary Prevention of Cardiovascular Disease in 38 Low-Income and Middle-Income Countries
M Yan, Z Liu, Y Zhu, X Lang, X Liu, B Hu… - Available at SSRN … - papers.ssrn.com
Background: The implementation of guideline recommendations on medication use,
metabolism and healthy lifestyle in patients with cardiovascular disease (CVD) in low …
metabolism and healthy lifestyle in patients with cardiovascular disease (CVD) in low …
[PDF][PDF] Innovations 2023 in Cardiology
A Pasquet, L Bamps, L Belkhir, M Dechamps… - dial.uclouvain.be
INNOVATIONS 2023 EN CARDIOLOGIE Page 1 129 Louvain M ed 2024 ; 143 (02-03) : 129-133
INNOVATIONS 2023 EN CARDIOLOGIE Retenons de cette année 2023 des nouvelles …
INNOVATIONS 2023 EN CARDIOLOGIE Retenons de cette année 2023 des nouvelles …
[引用][C] The global diagnostic network: what can we learn from half a billion lipid measurements between 2018 and 2020?
The 2022 World Heart Federation (WHF) Cholesterol Roadmap set out an implementation
strategy to prevent atherosclerotic cardiovascular disease (ASCVD) through considering …
strategy to prevent atherosclerotic cardiovascular disease (ASCVD) through considering …